Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.55 |
| ▸ | PGK1 | P00558 | 1/20 | 0.48 |
| ▸ | PGK2 | P07205 | 1/20 | 0.48 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2619139 | 1.00 | PGD (0.55) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL1972777 | 0.96 | PGD (0.55) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL28247642 | 0.89 | MPI (0.66) | PGDPGK1PGK2MPI | |
| SCHEMBL30899166 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL12189551 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL23888257 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL666269 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL20475921 | 0.85 | PGD (0.58) | PGDPGK1PGK2MPI | |
| SCHEMBL7748001 | 0.85 | PGD (0.58) | PGDPGK1PGK2MPI | |
| SCHEMBL5518494 | 0.85 | PGD (0.58) | PGDPGK1PGK2MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3772943-B1 | FORMULATION OF INSECTICIDAL MIXTURES WITH PROPYLENE CARBONATE | BAYER AG (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260098061-A1 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | PEPTIDREAM INC (JP) | 2026-04-09 | — | — | US | claimed |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| US-20250388939-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, S-NOROCLAURINE OR DERIVATIVES THEREOF | RIVER STONE BIOTECH APS (DK) | 2025-12-25 | — | — | US | claimed |
| EP-4060031-B1 | NOVEL DAHP SYNTHASE VARIANT, AND METHOD FOR PRODUCING L-LYSINE USING SAME | CJ CHEILJEDANG CORP (KR) | 2025-11-05 | — | — | EP | claimed |
| US-20250324977-A1 | ENGINEERED BACTERIA FOR ENHANCED CROP PRODUCTION | UNIV CALIFORNIA (US) | 2025-10-23 | — | — | US | claimed |
| US-20250295658-A1 | ANTIPARASITIC AGENTS AND METHODS | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | 2025-09-25 | — | — | US | claimed |
| EP-4615963-A1 | GENETICALLY MODIFIED BENZYLISOQUINOLINE ALKALOID-PRODUCING HOST CELLS WITH MODIFIED EFFLUX TRANSPORTER GENE EXPRESSION | River Stone Biotech ApS (DK) | 2025-09-17 | — | — | EP | claimed |
| US-20250283030-A1 | Biosynthesis of Phenylpropanoid Compounds | BGENE GENETICS (FR) | 2025-09-11 | — | — | US | claimed |
| US-20250268249-A1 | WATER DISPERSIBLE GRANULES WITH LOW MELTING ACTIVE INGREDIENTS PREPARED BY EXTRUSION | DISCOVERY PURCHASER CORPORATION | 2025-08-28 | — | — | US | claimed |
| US-20220112528-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, S-NOROCLAURINE OR DERIVATIVES THEREOF | RIVER STONE BIOTECH APS (DK) | 2022-04-14 | — | — | US | claimed |
| US-20220112431-A1 | FCC ADDITIVE COMPOSITION FOR BOTTOMS CRACKING AND A PROCESS FOR PREPARATION THEREOF | HINDUSTAN PETROLEUM CORPORATION LIMITED (IN) | 2022-04-14 | — | — | US | claimed |
| CN-114317306-A | Genetic engineering strain for synthesizing resveratrol and construction method and application thereof | 西北农林科技大学 | 2022-04-12 | — | — | CN | claimed |
| WO-2022072514-A1 | BIOCATALYTIC PRODUCTION OF PARA-HYDROXYBENZOIC ACID FROM METHANOL AND METHANE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-04-07 | — | — | WO | claimed |
| US-11266149-B2 | Herbicidal compositions | UNIVERSITY OF DURHAM (GB) | 2022-03-08 | — | — | US | claimed |
| WO-2022040457-A1 | ENGINEERED BIOSYNTHETIC PATHWAY FOR PRODUCTION OF 4-AMINOPHENYLETHYLAMINE BY FERMENTATION | ZYMERGEN INC. (US) | 2022-02-24 | — | — | WO | claimed |
| US-20220025412-A1 | Coryneform Bacterium Transformant and Method for Producing 2-Phenylethanol Using Same | RESEARCH INSTITUTE OF INNOVATIVE TECHNOLOGY FOR THE EARTH (JP) | 2022-01-27 | — | — | US | claimed |
| EP-3908654-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, (S)-NORCOCLAURINE OR DERIVATIVES THEREOF | River Stone Biotech ApS (DK) | 2021-11-17 | — | — | EP | claimed |
| WO-2021069714-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING BENZYLISOQUINOLINE ALKALOIDS | RIVER STONE BIOTECH APS (DK) | 2021-04-15 | — | — | WO | claimed |
| WO-2020144371-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, (S)-NORCOCLAURINE OR DERIVATIVES THEREOF. | RIVER STONE BIOTECH APS (DK) | 2020-07-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | TDO2, BLVRB, INMT | PGD 56/4885PGK1 454/4885PGK2 403/4885 |
| US-20260098061-A1 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | EPHA2, EPHA1, EPHB1 | PGD 4804/4885PGK1 3425/4885PGK2 3666/4885 |
| US-20250388939-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, S-NOROCLAURINE OR DERIVATIVES THEREOF | DBH, DDT, COMT | PGD 95/4885PGK1 706/4885PGK2 887/4885 |
| US-20250295658-A1 | ANTIPARASITIC AGENTS AND METHODS | DHFR, DHODH, MTHFD1 | PGD 92/4885PGK1 221/4885PGK2 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.